1. Zhou J, Liu B. Alzheimer's disease and prion protein. Intractable Rare Dis Res 2013; 2(2): 35-44. 2. Danysz W, Parsons CG. Alzheimer's disease, beta-amyloid, glutamate, NMDA receptors and memantine--searching for the connections. Br J Pharmacol 2012; 167(2): 324-52. 3. Singh S, Kushwah AS, Singh R, Farswan M, Kaur R. Current therapeutic strategy in Alzheimer's disease. Eur Rev Med Pharmacol Sci 2012; 16(12): 1651-64. 4. Takasugi N, Sasaki T, Shinohara M, Iwatsubo T, Tomita T. Synthetic ceramide analogues increase amyloid-beta 42 production by modulating gamma-secretase activity. Biochem Biophys Res Commun 2015; 457(2): 194-9. 5. He YX, Wu MN, Zhang H, Qi JS. Amyloid beta-protein suppressed nicotinic acetylcholine receptor-mediated currents in acutely isolated rat hippocampal CA1 pyramidal neurons. Synapse 2013; 67(1): 11-20. 6. Maatuk N, Samson AO. Modeling the binding mechanism of Alzheimer's Aβ1-42 to nicotinic acetylcholine receptors based on similarity with snake α-neurotoxins. Neurotoxicology 2013; 34: 236-42. 7. Hoppe JB, Frozza RL, Horn AP, Comiran RA, Bernardi A, Campos MM, et al. Amyloid-beta neurotoxicity in organotypic culture is attenuated by melatonin: involvement of GSK-3beta, tau and neuroinflammation. J Pineal Res 2010; 48(3): 230-8. 8. Piermartiri TC, Figueiredo CP, Rial D, Duarte FS, Bezerra SC, Mancini G, et al. Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-beta (1-40) administration in mice: evidence for dissociation between cognitive deficits and neuronal damage. Exp Neurol 2010; 226(2): 274-84. 9. Gulbrandsen TL, Sparks FT, Sutherland RJ. Interfering with post-learning hippocampal activity does not affect long-term consolidation of a context fear memory outside the hippocampus. Behav Brain Res 2013; 240: 103-9. 10. Pan YW, Storm DR, Xia Z. The Maintenance of Established Remote Contextual Fear Memory Requires ERK5 MAP Kinase and Ongoing Adult Neurogenesis in the Hippocampus. PLoS One 2012; 7(11): e50455. 11. Jo J, Whitcomb DJ, Olsen KM, Kerrigan TL, Lo SC, Bru-Mercier G, et al. Abeta(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3beta. Nat Neurosci 2011; 14(5): 545-7. 12. Origlia N, Capsoni S, Cattaneo A, Fang F, Arancio O, Yan SD, et al. Abeta-dependent Inhibition of LTP in different intracortical circuits of the visual cortex: the role of RAGE. J Alzheimers Dis. 2009; 17(1): 59-68. 13. Huang MY, Liao MH, Wang YK, Huang YS, Wen HC. Effect of lavender essential oil on LPS-stimulated inflammation. Am J Chin Med 2012; 40(4): 845-59. 14. Kim Y, Kim M, Kim H, Kim K. Effect of lavender oil on motor function and dopamine receptor expression in the olfactory bulb of mice. J Ethnopharmacol 2009; 125(1): 31-5. 15. Kashani MS, Tavirani MR, Talaei SA, Salami M. Aqueous extract of lavender (Lavandula angustifolia) improves the spatial performance of a rat model of Alzheimer's disease. Neurosci Bull 2011; 27(2): 99-106. 16. Soheili M, Tavirani MR, Salami M. Clearance of Amyloid Beta Plaques from Brain of Alzheimeric Rats by Lavandula angustifolia. Neurosci Med 2012; 3(4):6. 17. Soheili M, Salami M, Haghir A, Zali H, Rezaei Tavirani M. Aqueous Extract of Lavandula Angustifolia Alter Protein Expression in Alzheimer Rats. J Rep Pharm Sci 2014; 3(1): 9. 18. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates - The New Coronal Set: Elsevier Science; 2004. 19. Philippi N, Noblet V, Botzung A, Despres O, Renard F, Sfikas G, et al. MRI-Based Volumetry Correlates of Autobiographical Memory in Alzheimer's Disease. PLoS One 2012; 7(10): e46200. 20. Vargas LM, Leal N, Estrada LD, Gonzalez A, Serrano F, Araya K, et al. EphA4 activation of c-Abl mediates synaptic loss and LTP blockade caused by amyloid-beta oligomers. PLoS One 2014; 9(3): e92309. 21. Barry AE, Klyubin I, Mc Donald JM, Mably AJ, Farrell MA, Scott M, et al. Alzheimer's disease brain-derived amyloid-beta-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein. J Neurosci 2011; 31(20): 725. 22. Ni R, Marutle A, Nordberg A. Modulation of alpha7 Nicotinic Acetylcholine Receptor and Fibrillar Amyloid-beta Interactions in Alzheimer's Disease Brain. J Alzheimers Dis 2013; 33(3): 841-51. 23. Tomas M, Garcia N, Santafe MM, Lanuza M, Tomas J. Protein kinase C involvement in the acetylcholine release reduction induced by amyloid-beta(25-35) aggregates on neuromuscular synapses. J Alzheimers Dis 2009; 18(4): 877-84. 24. Hritcu L, Cioanca O, Hancianu M. Effects of lavender oil inhalation on improving scopolamine-induced spatial memory impairment in laboratory rats. Phytomedicine 2012; 19(6): 529-34. 25. Matos M, Augusto E, Machado NJ, dos Santos-Rodrigues A, Cunha RA, Agostinho P. Astrocytic adenosine A2A receptors control the amyloid-beta peptide-induced decrease of glutamate uptake. J Alzheimers Dis 2012; 31(3): 555-67. 26. Alberdi E, Sanchez-Gomez MV, Cavaliere F, Perez-Samartin A, Zugaza JL, Trullas R, et al. Amyloid beta oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors. Cell Calcium 2010; 47(3): 264-72. 27. Lin PW, Chan WC, Ng BF, Lam LC. Efficacy of aromatherapy (Lavandula angustifolia) as an intervention for agitated behaviours in Chinese older persons with dementia: a cross-over randomized trial. Int J Geriatr Psychiatry 2007; 22(5): 405-10. 28. Perez Nievas BG, Hammerschmidt T, Kummer MP, Terwel D, Leza JC, Heneka MT. Restraint stress increases neuroinflammation independently of amyloid beta levels in amyloid precursor protein/PS1 transgenic mice. J Neurochem 2011; 116(1): 43-52. 29. He FQ, Qiu BY, Zhang XH, Li TK, Xie Q, Cui DJ, et al. Tetrandrine attenuates spatial memory impairment and hippocampal neuroinflammation via inhibiting NF-kappaB activation in a rat model of Alzheimer's disease induced by amyloid-beta(1-42). Brain Res 2011; 1384: 89-96. 30. Fakhfouri G, Ahmadiani A, Rahimian R, Grolla AA, Moradi F, Haeri A. WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-gamma pathway. Neuropharmacology 2012; 63(4): 653-66. 31. Chen HQ, Jin ZY, Wang XJ, Xu XM, Deng L, Zhao JW. Luteolin protects dopaminergic neurons from inflammation-induced injury through inhibition of microglial activation. Neurosci Lett 2008; 448(2): 175-9. 32. Hajhashemi V, Ghannadi A, Sharif B. Anti-inflammatory and analgesic properties of the leaf extracts and essential oil of Lavandula angustifolia Mill. J Ethnopharmacol 2003; 89(1): 67-71. 33. Perry NS, Bollen C, Perry EK, Ballard C. Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial. Pharmacol Biochem Behav 2003; 75(3): 651-9.
|